ProPhase Labs, Inc.
PRPH
$0.10
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.74M | -41.70M | -41.45M | -43.13M | -53.36M |
| Total Depreciation and Amortization | 5.06M | 5.74M | 6.32M | 6.53M | 6.64M |
| Total Amortization of Deferred Charges | 5.24M | 2.32M | 1.97M | 1.72M | 1.49M |
| Total Other Non-Cash Items | -3.71M | 9.06M | 7.71M | 5.73M | 12.81M |
| Change in Net Operating Assets | -185.00K | 13.96M | 14.27M | 13.37M | 14.89M |
| Cash from Operations | -8.34M | -10.63M | -11.18M | -15.78M | -17.54M |
| Capital Expenditure | -- | -40.00K | -39.00K | -39.00K | -906.00K |
| Sale of Property, Plant, and Equipment | 120.00K | 120.00K | 199.00K | 282.00K | 229.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 800.00K | 800.00K | 623.00K | 597.00K | 3.10M |
| Cash from Investing | 920.00K | 880.00K | 783.00K | 840.00K | 2.42M |
| Total Debt Issued | 7.57M | 7.94M | 7.18M | 7.61M | 9.86M |
| Total Debt Repaid | -4.26M | -5.77M | -5.87M | -5.57M | -4.25M |
| Issuance of Common Stock | 3.56M | 6.53M | 6.53M | 10.87M | 7.59M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -35.00K | 959.00K | 953.00K | 947.00K | 978.00K |
| Cash from Financing | 6.84M | 9.66M | 8.79M | 13.85M | 14.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -588.00K | -96.00K | -1.61M | -1.09M | -931.00K |